HU9401900D0 - A therapeutic process for the treatment of the pathologies of type ii diabetes - Google Patents

A therapeutic process for the treatment of the pathologies of type ii diabetes

Info

Publication number
HU9401900D0
HU9401900D0 HU9401900A HU9401900A HU9401900D0 HU 9401900 D0 HU9401900 D0 HU 9401900D0 HU 9401900 A HU9401900 A HU 9401900A HU 9401900 A HU9401900 A HU 9401900A HU 9401900 D0 HU9401900 D0 HU 9401900D0
Authority
HU
Hungary
Prior art keywords
pathologies
diabetes
treatment
type
therapeutic process
Prior art date
Application number
HU9401900A
Other languages
Hungarian (hu)
Other versions
HUT67688A (en
Inventor
Albert H Meier
Anthony H Cincotta
Original Assignee
Ergo Science Inc
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ergo Science Inc, Univ Louisiana State filed Critical Ergo Science Inc
Publication of HU9401900D0 publication Critical patent/HU9401900D0/en
Publication of HUT67688A publication Critical patent/HUT67688A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9401900A 1991-12-23 1992-12-22 Preparations for treating pathologies of type ii HUT67688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81313591A 1991-12-23 1991-12-23

Publications (2)

Publication Number Publication Date
HU9401900D0 true HU9401900D0 (en) 1994-09-28
HUT67688A HUT67688A (en) 1995-04-28

Family

ID=25211542

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401900A HUT67688A (en) 1991-12-23 1992-12-22 Preparations for treating pathologies of type ii

Country Status (5)

Country Link
AU (1) AU3419293A (en)
CZ (1) CZ282909B6 (en)
HU (1) HUT67688A (en)
RU (1) RU2104698C1 (en)
WO (1) WO1993012793A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
ES2393303T3 (en) * 1996-05-07 2012-12-20 Veroscience Llc Medical use and composition for the treatment of disorders of lipid and glucose metabolism
US9655865B2 (en) * 2002-07-29 2017-05-23 Veroscience, Llc Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
AU2013263800B2 (en) * 2007-03-30 2016-05-05 Veroscience Llc Methods of treating metabolic syndrome using dopamine receptor agonists
WO2009062113A1 (en) 2007-11-07 2009-05-14 Burnham Institute For Medical Research Method and compounds for modulating insulin production
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
AU2014277952A1 (en) * 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN

Also Published As

Publication number Publication date
HUT67688A (en) 1995-04-28
AU3419293A (en) 1993-07-28
WO1993012793A1 (en) 1993-07-08
CZ282909B6 (en) 1997-11-12
CZ155494A3 (en) 1995-08-16
RU2104698C1 (en) 1998-02-20
RU94037557A (en) 1996-05-20

Similar Documents

Publication Publication Date Title
HU9201518D0 (en) Process for the production of a medical composition
HU9201548D0 (en) Process for the production of a medical composition
GB8719367D0 (en) Therapeutic compounds
GB2211726B (en) A therapeutic bed
GB8822852D0 (en) Dosage form for treating cardiovascular diseases
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
HU9401900D0 (en) A therapeutic process for the treatment of the pathologies of type ii diabetes
IL103205A0 (en) Compounds for treating leukotriene-related diseases
GB8725939D0 (en) Therapeutic compounds
GR3022446T3 (en) Apparatus for the continuous treatment of a linear manufacture
ZA915214B (en) Pharmaceutical treatment
ZA913844B (en) Therapeutic product
ZA932450B (en) Drugs for the treatment of diabetes
GB2225570B (en) Continuous treatment process
AU662876B3 (en) A therapeutic process for the treatment of the pathologies of type II diabetes
GB9125678D0 (en) Catalyst treatment process
HU911198D0 (en) Process for the production of a medical preparation
GB9117819D0 (en) Therapeutic compounds
GB8724564D0 (en) Therapeutic compounds
GB2243602B (en) Treatment process
GB9005792D0 (en) Treatment process
GB9107312D0 (en) Process for the treatment of effluent
GB9005050D0 (en) Treatment of diabetes
GB9324852D0 (en) A medicament for the treatment of metasteses
GB2242424B (en) Treatment process

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee